Previously, our in vitro studies provided that HLA-G expression in hepatocellular carcinoma and ovarian carcinoma cell lines could directly inhibit NK cell lysis, and blocking with HLA-G antibodies restored the NK-mediated lysis of the targeted cancer cell lines (68, 69). This evidence concerns the gene HLA-G and cancer.